Health and Care Professions Council determination — review hearing
HCPTS finds Mark Fraser Edgar no longer impaired at suspension review
The HCPTS panel accepted evidence of insight and remediation. Mark Fraser Edgar's suspension will lapse at the end of 26 September 2026, rather than being revoked immediately.
MedicWatch editorial · Published 29 July 2026 · Updated 22 September 2026
No impairment found
Data last checked: 22 September 2026Report a correction
What does “no impairment found” mean?
The regulator found no current impairment in this decision. Read the decision for its effect on any existing order and check the official register for the practitioner's current status.
Concerning Mark Fraser Edgar, hearing aid dispenser (Health and Care Professions Council HAD00451).
Decision date: 29 July 2026 · Hearing started 29 July 2026
In plain English
The HCPTS panel found hearing aid dispenser Mark Fraser Edgar no longer impaired after reviewing his suspension for dishonest expense claims. It accepted evidence of developed insight, remediation and safeguards, and considered repetition highly unlikely. The panel allowed the suspension to lapse at the end of 26 September 2026. It expressly declined immediate revocation because the hearing was a mandatory review.
Charges
The review followed a 12-month suspension imposed after findings of dishonest expense claims over a lengthy period. The original panel had not proved the allegation relating to meal expenses but had found the other specified particulars proved.
Findings
The review panel found no continuing impairment on either the personal or public component. It accepted substantial evidence of insight, remediation, financial safeguards and professional references, and considered repetition highly unlikely. It expressly declined to revoke the order immediately because this was a mandatory review. The suspension will lapse at the end of 26 September 2026.
Source
All facts on this page are drawn from the publicly published Health and Care Professions Council determination linked below. MedicWatch does not editorialise the regulator’s findings.
Spot something incorrect?
If a fact on this page is wrong, or you believe the page should not be published, please submit a correction or takedown request.